New U.S. Policy Seeks to Restrict High-Risk, Gain-of-Function Biology Research

New framework ends federal support for dangerous gain-of-function research, strengthens oversight of other high-risk life sciences research, and restricts funding for research conducted in countries that lack appropriate biosafety standards.